Monitoring of the content of phenobarbital and dilantin in blood

MAO Xiao-qin,JIA Xiong-fei,ZHANG Yuan
2013-01-01
Abstract:OBJECTIVE To analyze the content of phenobarbital and dilantin in blood of patients with epilepsia, so as to provide basis for content of drug and treatment strategy. METHODS A total of 247 patients with phenobarbital and dilantin treatment were collected. The content of phenobarbital and dilantin in blood were analyzed. The toxicity and adverse effects were also analyzed. RESULTS The effective blood drug concentration of phenobarbital in blood accounted for 42.59% , which significantly higher than patients with high concentration (2.78%). 54.63% of the patients were within the effective blood drug concentration.Among patients with dilantin, 29.50% of them had lower effective blood drug concentration, and 7.91% of them had higher effective blood drug concentration. 62.59% of them were within the effective blood drug concentration. Among 247 patients , no one showed toxic reaction. 3 patients showed gastrointestinal adverse effects. 2 patients were treated with phenobarbital , and the blood concentration was﹥40μg / ml. One patient with dilantin had the blood concentration of ﹥20μg / ml. One patients with phenobarbital treatment showed adverse reactions in nervous system, and the blood drug concentration was ﹥ 40μg / ml. CONCLUSION We should give individual treatment according to the blood drug concentration.
What problem does this paper attempt to address?